# 바이오스페이스 일일 뉴스 리포트 - 2025년 09월 11일


## 주요 헤드라인

1. **Odyssey Rebounds Off Failed IPO With $213M Series D (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/odyssey-rebounds-off-failed-ipo-with-213m-series-d>

2. **Odyssey Rebounds Off Failed IPO With $213M Series D (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/odyssey-rebounds-off-failed-ipo-with-213m-series-d>

3. **Novo’s Headcount Rose 81% in Five Years as Revenue Climbed (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novos-headcount-rose-81-in-five-years-as-revenue-climbed>

4. **Novo’s Headcount Rose 81% in Five Years as Revenue Climbed (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novos-headcount-rose-81-in-five-years-as-revenue-climbed>

5. **Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lundbeck-offloads-assets-to-three-partners-as-it-exits-27-markets-leaving-602-jobless>

6. **Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lundbeck-offloads-assets-to-three-partners-as-it-exits-27-markets-leaving-602-jobless>

7. **Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/amgen-kyowa-kirin-bolster-safety-profile-for-atopic-dermatitis-hopeful>


---
*2025년 09월 11일 바이오스페이스 뉴스 피드에서 생성된 리포트*